Our previous study showed that ZSWIM4 could mediate resistance to apoptosis induced by a non-receptor-type tyrosine-protein Janus kinase 2 (JAK2) inhibitor by upregulating vitamin D receptor levels in breast cancer cells. Here, ZSWIM4 is linked to breast cancer.